Trelegy ellipta and Fenoterol hydrobromide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Trelegy ellipta (fluticasone furoate; umeclidinium bromide; vilanterol trifenatate) and Fenoterol hydrobromide (fenoterol hydrobromide). Common drug interactions include arthralgia among females and hyponatraemia among males.

The phase IV clinical study analyzes what interactions people have when they take Trelegy ellipta and Fenoterol hydrobromide. It is created by eHealthMe based on reports of 72 people who take the same drugs from the FDA, and is updated regularly.

What is Trelegy ellipta?

Trelegy ellipta has active ingredients of fluticasone furoate; umeclidinium bromide; vilanterol trifenatate. eHealthMe is studying from 28,101 Trelegy ellipta users. Check the latest studies of Trelegy ellipta.

What is Fenoterol hydrobromide?

Fenoterol hydrobromide has active ingredients of fenoterol hydrobromide. eHealthMe is studying from 1,327 Fenoterol hydrobromide users. Check the latest studies of Fenoterol hydrobromide.

On Aug, 07, 2026

72 people who take Trelegy ellipta and Fenoterol hydrobromide together, and have interactions are studied.

Trelegy ellipta and Fenoterol hydrobromide drug interactions.

What are the common drug interactions of Trelegy Ellipta and Fenoterol Hydrobromide, by gender? *:

female:

Arthralgia (joint pain)
Joint swelling
Death
Pneumonia
Type iii immune complex mediated reaction

male:

Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Abdominal distension
Drug hypersensitivity
General physical health deterioration (weak health status)
Nausea (feeling of having an urge to vomit)
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
Abdominal pain
Appendicitis (inflammation of the appendix)
Ascites (accumulation of fluid in the abdominal cavity)
Cardiogenic shock (inadequate circulation of blood)

What are the common drug interactions of Trelegy Ellipta and Fenoterol Hydrobromide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Nightmare (unpleasant dream)
Arthralgia (joint pain)
Joint swelling
Type iii immune complex mediated reaction

50-59:

Gamma-glutamyltransferase increased
Plasma cell myeloma (cancer that begins in plasma cells)
Renal disorder (kidney disease)
General physical health deterioration (weak health status)
White blood cell count decreased
Conjunctivitis (pink eye)
Escherichia urinary tract infection (urinary tract infection by escherichia coli)
Pneumonia klebsiella (pneumonia caused by bacteria klebsiella)
Platelet count decreased
Stomatitis (inflammation of mucous membrane of mouth)

60+:

Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Abdominal distension
Drug hypersensitivity
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
Abdominal pain
Appendicitis (inflammation of the appendix)
Ascites (accumulation of fluid in the abdominal cavity)
Cardiogenic shock (inadequate circulation of blood)
Constipation
General physical health deterioration (weak health status)

What are the existing conditions these people have? *

Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 63 people, 87.50%
Stress And Anxiety: 45 people, 62.50%
Bacterial Infection: 42 people, 58.33%
Ventricular Fibrillation (abnormally irregular heart rhythm): 40 people, 55.56%
Blood Phosphorus Increased: 40 people, 55.56%
Diabetes: 40 people, 55.56%
Constipation: 40 people, 55.56%
High Blood Cholesterol: 40 people, 55.56%
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 40 people, 55.56%
Cardiogenic Shock (inadequate circulation of blood): 40 people, 55.56%

* Approximation only. Some reports may have incomplete information.

Do you take Trelegy ellipta and Fenoterol hydrobromide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously